期刊文献+

茴拉西坦辅助治疗精神分裂症的对照研究

下载PDF
导出
摘要 目的探讨茴拉西坦对精神分裂症的辅助疗效。方法将120例精神分裂症患者随机分为2组,分别在使用抗精神病药物时使用或不使用茴拉西坦辅助治疗。疗程8周,采用阳性和阴性症状量表(PANSS)评定疗效。结果使用茴拉西坦辅助治疗疗效明显较好。结论茴拉西坦对精神分裂症有明显辅助疗效。
作者 刘春辉
出处 《现代中西医结合杂志》 CAS 2007年第29期4297-4297,共1页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献3

  • 1Nakamura K,Tanaka Y.Antidepressant-like effects of aniracetam in aged rats and its mode of action[J].Psychopharmacotogy (Berl),2001,158(2):205-212
  • 2刘铁桥,徐利敏,陈晓岗,刘宗奇.茴拉西坦在精神科的临床应用[J].国外医学(精神病学分册),2005,32(1):1-3. 被引量:4
  • 3Nakamura K.Aniracetam:its novel therapeutic Potential in cerebral dysfunctional disorders based on recent pharmacological discoveries[J].CNS Drug Rev,2002,8(1):70-89

二级参考文献15

  • 1Nakamura K, Kurasawa M, Tanaka Y. Apomorphine - induced hypoattention in rats and reversal of the choice performance impairment by aniracetam. Eur J Pharmacol. 1998; 342 (2-3): 127-138.
  • 2Nakamura K. Tanaka Y: Antidepressant-like effects of aniracetam in aged rats and its mode of action. Psychopharmacology (Berl), 2001 Nov; 158 (2): 205 212.
  • 3Nakamura K, Kurasawa M : Aniracetam restores motivation reduced by situation in a choice reaction task in agedrats. Pharmacol Biochem Behav. 2001 Jan; 68(1 ) : 65-69.
  • 4Nakamura K, Kurasawa M : Anxiolytic effects of aniracetam in three different mouse models of anxiety and th eunderlying mechanism. Eur J Pharmacol. 2001; ,t20(1): 33-43.
  • 5Shirane M, Nakamura K: Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP. Brain Res. 2001,916(1-2): 211-221.
  • 6Ouchi Y, Kakiuchi T ,Okada H,et al:The effect of aniracetam on cerebral glucose metabolism in rats after lesioning of the basal forebrain measured by PET. J Neurol Sci.1999; 164 (1): 7-12.
  • 7Nakamura K, Shirane M : Activation of the reticulothalamic cholinergic pathway by the major metaholites of aniracetam. Eur J Pharmacol. 1999; 380 (2-3): 81-89.
  • 8Petkov VD, Mosharrof AH, Petkov VV, et al:Age-related differences in memory and in the memory effects of nootropic drugs. Acta Physiol Pharmacol Bulg. 1990; 16(2) : 28 36.
  • 9Miyamoto H, Yaguchi T, Ohta K, et al: 2-pyrrolidinone induces a long-lasting facilitation of hippocampal synaptic transmission by enhancing alpha7 Ach receptor responses via a PKC pathway. Brain Res Mol Brain Res. 2003; 117(1): 91-96.
  • 10Senin U, Abate G, Fieschi C, et al: Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT) : results of a placebo controlled muhicentre clinical study. Eur Neuropsychopharmacoh 1991 Dec; 1(4): 511-517.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部